RecruitingNCT07046585

Evaluation of the Natera Colorectal Cancer Screening Test in an Average Risk Population (FIND-CRC)

Sponsor

Natera, Inc.

Enrollment

25,000 participants

Start Date

May 30, 2025

Study Type

OBSERVATIONAL

Conditions

Colo-rectal Cancer

Summary

The FIND-CRC study is a prospective collection of samples and data from participants who are at average risk of developing colorectal cancer (CRC). Collected samples and data will be analyzed to evaluate the clinical performance of the Natera CRC Screening Test.

Eligibility

Min Age: 40 Years

Inclusion Criteria6

Signed informed consent.
years of age or older at the time of consent.
Planning or intending to undergo a standard of care colonoscopy.
Able to tolerate venipuncture for research draw(s).
Able and willing to provide blood samples within the 120 days prior to a standard-of-care pre-bowel preparation procedure and colonoscopy procedure.
Willing and able to comply with the study visit schedule and study requirements.

Exclusion Criteria8

Any prior history of any kind of malignancy (exception: participants who have undergone surgical removal of skin squamous cell or basal cell cancers may be enrolled, provided the procedure was completed at least 12 months prior to consent for the study).
Had a complete colonoscopy with adequate bowel preparation in the previous nine (9) years.
Undergoing diagnostic colonoscopy for the investigation of symptoms.
Up to date with colorectal cancer screening from any non-invasive test.
Precancerous findings on most recent colonoscopy.
Had a prior colorectal resection for any reason other than sigmoid diverticular disease.
Known personal history of any of the following high-risk conditions:
a. Inflammatory bowel disease. 7b. Known hereditary condition that would increase risk of colorectal cancer (example Lynch Syndrome).